Publications by authors named "Kevin Epps"

Claim this Profile
I
Impact of Hypoalbuminemia on Clinical Outcomes in Patients Receiving Cefazolin for Methicillin-Susceptible Bacteremia.
Kaylee M Whitenack, Dan Ilges, Kevin L Epps, Alyssa McGary, John C Robinson

Ann Pharmacother· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of a Methicillin-Resistant Staphylococcus Aureus Nasal Polymerase Chain Reaction Protocol on Vancomycin Length of Therapy Among Patients With Skin and Soft Tissue Infections.
Anel Couzo, Adia Griffin, Courtney M Willis, Julio Mendez, Kevin L Epps

J Pharm Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological and chemical properties of new multi-functional root canal irrigants.
Nidambur Vasudev Ballal, Rajkumar Narkedamalli, Padmaja A Shenoy, Shubhankar Das, Saravana Karthikeyan Balasubramanian, Kevin Epps

J Dent· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "Higher may not be better".
Alexei Gonzalez-Estrada, Ismael Carrillo-Martin, W Tatiana Garzon-Siatoya, Hajara Joundi, Dan Morgenstern-Kaplan, Kevin L Epps

J Allergy Clin Immunol Pract· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Immediate and Delayed Maximal Nonirritating Skin Testing Concentrations of β-Lactam Antibiotics.
Alexei Gonzalez-Estrada, Ismael Carrillo-Martin, W Tatiana Garzon-Siatoya, Hajara Joundi, Dan Morgenstern-Kaplan, Kevin L Epps

J Allergy Clin Immunol Pract· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLinician and patient characteristics effect on Antimicrobial Stewardship Interventions (CLASI) study.
Sara E Ausman, Kristin C Mara, Caitlin S Brown, Kevin L Epps, Kirstin Kooda

Infect Control Hosp Epidemiol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Oral and Intravenous Definitive Antibiotic Therapy for Beta-Hemolytic Streptococcus Species Bloodstream Infections from Soft Tissue Sources: a Propensity Score-Matched Analysis.
Zachary A Yetmar, Supavit Chesdachai, Brian D Lahr, Douglas W Challener, Kellie N Arensman Hannan, Kevin Epps

Antimicrob Agents Chemother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist-led improvement in perioperative antibiotic selection for patients with a penicillin allergy label.
Devon Stonerock, Alejandro Hallo-Carrasco, Michael Edwards, Steven B Porter, Kevin L Epps

Am J Health Syst Pharm· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring following crushed administration of delayed-release posaconazole tablets via enteral feeding tubes.
Ryan W Stevens, Casey O'Connell, Angie Huang, Kevin L Epps, Dan Ilges

J Antimicrob Chemother· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of an electronic health system-based best-practice advisory to enhance the time to de-escalation of vancomycin for respiratory indications.
Amanda C Gibbs, Daniel A Jackson, Senka Runjaic, Vanessa J Toncray, Wendelyn Bosch, Kevin L Epps

Antimicrob Steward Healthc Epidemiol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the art in cystic fibrosis pharmacology optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: III. Executive summary.
Quovadis J Epps, Kevin L Epps, David C Young, Jeffery T Zobell

Pediatr Pulmonol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. Cephalosporins and penicillins latest update.
Quovadis J Epps, Kevin L Epps, Jeffery T Zobell

Pediatr Pulmonol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model.
Raymund R Razonable, Nicole C E Aloia, Ryan J Anderson, Gokhan Anil, Lori L Arndt, Kevin Epps

Mayo Clin Proc· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations:  II. Therapies for allergic bronchopulmonary aspergillosis.
Quovadis J Epps, Kevin L Epps, Jeffery T Zobell, David C Young

Pediatr Pulmonol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
Quovadis J Epps, Kevin L Epps, David C Young, Jeffery T Zobell

Pediatr Pulmonol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inpatient β-lactam test-dose protocol and antimicrobial stewardship in patients with a history of penicillin allergy.
Keith A Sacco, Benjamin P Cochran, Kevin Epps, Mark Parkulo, Alexei Gonzalez-Estrada

Ann Allergy Asthma Immunol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initiative to reduce aztreonam use in patients with self-reported penicillin allergy: Effects on clinical outcomes and antibiotic prescribing patterns.
Anthony Phan, Bryan Allen, Kevin Epps, Maryam Alikhil, Katherine Kamataris

Am J Health Syst Pharm· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a pharmacist-driven methicillin-resistant surveillance protocol.
Courtney Willis, Bryan Allen, Calvin Tucker, Kathleen Rottman, Kevin Epps

Am J Health Syst Pharm· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. Cephalosporins and penicillins update.
Jeffery T Zobell, Kevin L Epps, David C Young

Pediatr Pulmonol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vancomycin Dosing and Monitoring in the Treatment of Cystic Fibrosis: Results of a National Practice Survey.
Rebecca S Pettit, Stacy J Peters, Erin J McDade, Kaci Kreilein, Radha Patel, Kevin Epps

J Pediatr Pharmacol Ther· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tobramycin and Beta-Lactam Antibiotic Use in Cystic Fibrosis Exacerbations: A Pharmacist Approach.
Jeffery T Zobell, Kevin Epps, Frederick Kittell, Clarissa Sema, Erin J McDade

J Pediatr Pharmacol Ther· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
Jeffery T Zobell, Kevin L Epps, David C Young, Madison Montague, Jared Olson

Pediatr Pulmonol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis